Koji Kato, Keigo Yamada, Mizuki Maehara, Fumiaki Akama, Keitaro Kimoto, Mai Saito, Hiroshi Yano, Atsushi Ichimura, Hideo Matsumoto
Index: Psychiatry Clin. Neurosci. 65(4) , 389-91, (2011)
Full Text: HTML
The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive patients with delirium in the ICU were retrospectively reviewed. These patients were treated with blonanserin. A total of 96.6% had reduction in Memorial Delirium Assessment Scale score. The proportion of patients with side-effects was 24.1%. Blonanserin may be effective and safe in the treatment of delirium in the ICU.© 2011 The Authors. Psychiatry and Clinical Neurosciences © 2011 Japanese Society of Psychiatry and Neurology.
| Structure | Name/CAS No. | Molecular Formula | Articles |
|---|---|---|---|
![]() |
Blonanserin
CAS:132810-10-7 |
C23H30FN3 |
|
Asenapine, blonanserin, iloperidone, lurasidone, and sertind...
2013-01-01 [Clin. Neuropharmacol. 36(6) , 223-38, (2013)] |
|
Five Alzheimer's disease cases with refractory behavioural p...
2010-12-01 [Psychogeriatrics 10(4) , 198-200, (2010)] |
|
Development and validation of a stability-indicating gas chr...
2012-09-01 [J. Chromatogr. Sci. 50(8) , 727-32, (2012)] |
|
Quetiapine-induced insulin resistance after switching from b...
2012-10-01 [Psychiatry Clin. Neurosci. 66(6) , 534-5, (2012)] |
|
Improvement in quetiapine-induced hypoglycemia following a s...
2012-06-01 [Psychiatry Clin. Neurosci. 66(4) , 370-1, (2012)] |
Home | MSDS/SDS Database Search | Journals | Product Classification | Biologically Active Compounds | Selling Leads | About Us | Disclaimer
Copyright © 2024 ChemSrc All Rights Reserved
